Centers | ||
|
|
|
EU-OPENSCREEN | Chemical Genomics Facility at Purdue Institute for Drug Discovery | Collaborative Drug Discovery, Inc. |
EU-OPENSCREEN is a multinational, not-for-profit initiative, which
integrates high-capacity screening platforms and chemistry groups across
Europe. The aim of this initiative is to support individual scientists
interested in chemical biology... |
The Chemical Genomics Facility is a core facility at Purdue Institute for Drug Discovery that provides expertise and resources needed in the early stage of drug discovery. The services include small molecule libraries, access to automated equipment... Read more |
Chemical registration system Activity & Registration - Web application within CDD Vault for chemical registration, assay data management, and SAR analysis. |
Partnerships |
Events |
Jobs |
Cerecor Partners with Johns Hopkins Brain Science Institute to Treat SchizophreniaCerecor a Baltimore based company has taken an option with Johns Hopkins University to license D-Amino Acid Oxidase inhibitors (DAAO) to treat Schizophrenia. The DAAO inhibitor molecules are currently being developed by researchers at the Johns... View all Vanderbilt Enters Into Collaboration With BMS to Develop Drugs to treat Parkinsons DiseaseVanderbilt Center for Neuroscience Drug Discovery (VCNDD) and Bristol-Myers Squibb Company have entered into a broad collaboration agreement to co-develop new drugs to treat Parkinsons Disease. Under the collaboration agreement VCNDD will identify... View all Elan and University of Cambridge Establish New Innovation CenterUniversity of Cambridge and Elan jointly established Cambridge - Elan Centre for Research Innovation and Drug Discovery. The new center will be based out of Cambridge and will focus primarily in developing innovative therapies to treat Alzheimer's... View all |
No EVENTS for listing |
No Job Posts |
